DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 17.19.
| Share Price | ₹6,835.7 | Jul 10,2026 |
| Market Cap | ₹181,487.8 Cr | |
| Sales-TTM | ₹10,560.0 Cr | TTM-Consolidated Results |
| Price/Sales | 17.19x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹181,487.8 Cr] as on Jul 10,2026
(/) Sales [ ₹10,560.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 17.19x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '17.19 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.89x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| DIVIS LABORATORIES | 10,560.0 | 17.19 | 181,487.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.94 | 464,331.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.87 | 165,952.0 |
| CIPLA LTD | 28,162.6 | 4.13 | 116,229.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.08 | 103,959.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.30 | 104,275.0 |
| LUPIN LTD | 27,958.0 | 4.08 | 114,128.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.23 | 114,763.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.68 | 90,026.5 |
| LAURUS LABS LTD | 6,812.9 | 12.20 | 83,103.9 |
| BIOCON LTD | 16,927.0 | 4.03 | 68,194.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.68x |
| Max industry PS | 17.19x |
| Median industry PS | 4.23x |
| Average industry PS | 7.16x |
You may also like the below Video Courses